5. Conclusions
dysuria, climacteric syndrome, prostate
ADVERSE EFFECTS, BPH, CLIMACTERIC SYNDROME, PROSTATE
A 12-week regimen of BRE supplementation in middle-aged and older men with climacteric syndrome was not effective in alleviating symptoms of andropause. However, it did result in reductions in TC and LDL-C levels in the blood, with no reported adverse effects. Moreover, improved IPSS scores suggested easier urination, indicating improved prostate health. As a result, we observed a significant improvement in the quality of life, as evidenced by the scores on the IPSS-QoL index. Overall, this study provides robust evidence supporting the safety of BRE as a functional food. Its supplementation potentially enhances lipid metabolism and alleviates dysuria symptoms, thus limiting the development of BPH.